Skip to content
Home/Companies/Biotech/HAYA Therapeutics
HT

HAYA Therapeutics

Biotech·Switzerland·Active·5yr hold

Haya Therapeutics is a healthcare / biotech company, headquartered in Switzerland.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns HAYA Therapeutics?

HAYA Therapeutics is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund II (2021 vintage), since 2021. Across its history, HAYA Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Apollo Health Ventures
Most recent investor
Apollo Health Ventures
Apollo Health Ventures Fund II · 2021 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQSwitzerland
SectorHealthcare / Biotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Apollo Health Ventures and Sofinnova Partners since 2021.
Co-invest · 2 holders · 2021 · present
Apollo Health Ventures
Apollo Health VenturesActive
2021 · present · Apollo Health Ventures Fund II · 2021 · Life Sciences VC
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2021 · present · Sofinnova Capital X · 2021 · Life Sciences VC
MOIC
–

More from Apollo Health Ventures Fund II

Other portfolio companies in the same fund.

Therini Bio
Active
BiotechUnited States· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Auron Therapeutics
Active
BiotechUnited States· 2022
Cleara Biotech
Active
BiotechNetherlands· 2022
Focal Biosciences
Active
BiotechSwitzerland· 2022
Bloom Science
Active
BiotechUnited States· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings